Promiscuous_JJ methylation_NN of_IN non-canonical_JJ DNA_NN sites_NNS by_IN HaeIII_NP methyltransferase_NN The_DT cytosine_NN C5_NP methyltransferase_NP M.HaeIII_NP recognises_VBZ and_CC methylates_VBZ the_DT central_JJ cytosine_NN of_IN its_PP$ canonical_JJ site_NN GGCC_NP ._SENT Here_RB we_PP report_VBP that_IN M.HaeIII_NP can_MD also_RB ,_, with_IN lower_JJR efficiency_NN ,_, methylate_NN cytosines_NNS located_VBN in_IN a_DT wide_JJ range_NN of_IN non-canonical_JJ sequences_NNS ._SENT Using_VBG bisulphite_NN sequencing_VBG we_PP mapped_VBD the_DT methyl-_NN cytosine_NN residues_NNS in_IN DNA_NN methylated_VBN in_IN vitro_NN and_CC in_IN vivo_JJ by_IN M.HaeIII_NP ._SENT Methyl-cytosine_NP residues_NNS were_VBD observed_VBN in_IN multiple_JJ sequence_NN contexts_NNS ,_, most_RBS commonly_RB ,_, but_CC not_RB exclusively_RB ,_, at_IN star_JJ sites_NNS (_( sites_NNS differing_VBG by_IN a_DT single_JJ base_NN from_IN the_DT canonical_JJ sequence_NN )_) ._SENT The_DT most_RBS frequently_RB used_VBN star_NN sites_NNS had_VBD changes_NNS at_IN positions_NNS 1_CD and_CC 4_CD ,_, but_CC there_EX is_VBZ little_JJ or_CC no_DT methylation_NN at_IN star_NN sites_NNS changed_VBN at_IN position_NN 2_CD ._SENT The_DT rate_NN of_IN methylation_NN of_IN non-canonical_JJ sites_NNS can_MD be_VB quite_RB significant_JJ :_: a_DT DNA_NN substrate_NN lacking_VBG a_DT canonical_JJ site_NN was_VBD methylated_VBN by_IN M.HaeIII_NP in_IN vitro_NN at_IN a_DT rate_NN only_RB an_DT order_NN of_IN magnitude_NN slower_JJR than_IN an_DT otherwise_RB identical_JJ substrate_NN containing_VBG the_DT canonical_JJ site_NN ._SENT In_IN vivo_JJ methylation_NN of_IN non-canonical_JJ sites_NNS may_MD therefore_RB be_VB significant_JJ and_CC may_MD have_VB provided_VBN the_DT starting_VBG point_NN for_IN the_DT evolution_NN of_IN restriction_NN --_: modification_NN systems_NNS with_IN novel_JJ sequence_NN specificities_NNS ._SENT DNA_NP cytosine_NN C5_NP methyltransferases_NNS are_VBP a_DT large_JJ group_NN of_IN enzymes_NNS whose_WP$ structure_NN is_VBZ conserved_VBN in_IN bacteria_NNS ,_, archaea_NNS and_CC eukaryotes_NNS ._SENT This_DT class_NN of_IN enzymes_NNS has_VBZ a_DT common_JJ mechanism_NN of_IN catalysis_NN and_CC 10_CD highly_RB conserved_VBN motifs_NNS making_VBG up_RP the_DT catalytic_JJ site_NN and_CC the_DT cofactor_NN binding_VBG site_NN ._SENT In_IN eukaryotes_NNS ,_, cytosine_NN C5_NN methyltransferases_NNS are_VBP responsible_JJ for_IN CpG_NP methylation_NN ,_, which_WDT is_VBZ involved_VBN in_IN regulation_NN of_IN chromatin_NN structure_NN and_CC gene_NN expression_NN ._SENT In_IN bacteria_NNS ,_, DNA_NN methylation_NN has_VBZ roles_NNS in_IN restriction_NN --_: modification_NN (_( R_NN /M_NN )_) systems_NNS ,_, the_DT control_NN of_IN DNA_NN replication_NN and_CC post-replicative_JJ mismatch_NN repair_NN ._SENT Bacteria_NNS possessing_VBG a_DT R_NP /M_NN system_NN express_VBP a_DT methylase_NN and_CC cognate_JJ restriction_NN endonuclease_NN which_WDT recognise_VBP the_DT same_JJ target_NN site_NN ._SENT Methylation_NN of_IN the_DT bacterial_JJ chromosome_NN protects_VBZ it_PP from_IN endonuclease_NN digestion_NN ,_, but_CC unmethylated_JJ DNA_NN of_IN infecting_VBG bacteriophage_NN is_VBZ digested_VBN by_IN the_DT endonuclease_NN ._SENT Type_NN II_NP R_NP /M_NN systems_NNS are_VBP the_DT most_RBS common_JJ ,_, with_IN over_IN 200_CD DNA_NN specificities_NNS ._SENT The_DT evolution_NN of_IN a_DT R_NP /M_NN system_NN with_IN a_DT novel_NN specificity_NN must_MD necessarily_RB involve_VB the_DT co-evolution_NN of_IN both_CC a_DT methylase_NN and_CC a_DT restriction_NN endonuclease_NN ;_: however_RB ,_, little_RB is_VBZ known_VBN about_RB how_WRB this_DT might_MD occur_VB (_( --_: )_) ._SENT Both_CC a_DT methyltransferase_NN and_CC a_DT restriction_NN enzyme_NN with_IN novel_JJ sequence_NN specificity_NN must_MD evolve_VB ,_, yet_RB a_DT simultaneous_JJ change_NN in_IN sequence_NN specificity_NN is_VBZ not_RB likely_JJ ._SENT Due_JJ to_TO the_DT lethal_JJ nature_NN of_IN a_DT novel_JJ restriction_NN enzyme_NN without_IN a_DT cognate_JJ methyltransferase_NN ,_, the_DT methyltransferase_NN must_MD change_VB its_PP$ specificity_NN first_RB ._SENT Several_JJ models_NNS for_IN this_DT co-evolution_NN have_VBP been_VBN suggested_VBN ,_, including_VBG duplication_NN of_IN the_DT methyltransferase_NN gene_NN and_CC its_PP$ cognate_JJ restriction_NN endonuclease_NN gene_NN (_( the_DT two_CD genes_NNS are_VBP frequently_RB in_IN close_JJ proximity_NN )_) followed_VBN by_IN changes_NNS in_IN sequence_NN specificity_NN ._SENT This_DT switch_NN in_IN specificity_NN may_MD start_VB with_IN the_DT enhancement_NN of_IN activity_NN towards_IN a_DT non-canonical_JJ site_NN against_IN which_WDT the_DT enzyme_NN already_RB has_VBZ low_JJ activity_NN (_( ,_, )_) ,_, as_RB proposed_VBN for_IN other_JJ enzymes_NNS (_( ,_, )_) ._SENT Star_JJ activity_NN of_IN restriction_NN endonucleases_NNS ,_, when_WRB the_DT enzyme_NN recognises_VBZ and_CC cuts_VBZ at_IN a_DT sequence_NN differing_VBG at_IN only_RB a_DT single_JJ base_NN pair_NN from_IN the_DT canonical_JJ site_NN ,_, is_VBZ a_DT relatively_RB well_RB documented_VBN phenomenon_NN (_( ,_, )_) ._SENT In_IN contrast_NN ,_, DNA_NN methylation_NN is_VBZ generally_RB regarded_VBN as_IN being_VBG highly_RB sequence_NN specific_NN ,_, with_IN few_JJ published_VBN observations_NNS of_IN non-canonical_JJ methylation_NN ._SENT However_RB ,_, non-canonical_JJ ,_, or_CC aberrant_JJ ,_, methylation_NN has_VBZ been_VBN observed_VBN with_IN DNA_NN methyltransferases_NNS at_IN sites_NNS closely_RB related_VBN to_TO the_DT normal_JJ target_NN sequence_NN (_( ,_, ,_, --_: )_) ._SENT Here_RB we_PP report_VBP an_DT investigation_NN into_IN methylation_NN of_IN non-canonical_JJ sites_NNS by_IN the_DT cytosine_NN C5_NP methyltransferase_NP M.HaeIII_NP which_WDT is_VBZ part_NN of_IN a_DT typical_JJ type_NN II_NP R_NP /M_NN system_NN in_IN the_DT bacterium_NN Haemophilus_NP influenzae_NP (_( biogroup_NN aegyptius_NN )_) ._SENT M.HaeIII_NP methylates_VBZ the_DT third_JJ base_NN of_IN the_DT sequence_NN GGCC_NN in_IN unmodified_JJ or_CC hemimethylated_JJ duplex_JJ DNA_NN ._SENT We_PP have_VBP investigated_VBN the_DT optimum_JJ conditions_NNS for_IN methylation_NN by_IN M.HaeIII_NP at_IN canonical_JJ and_CC non-canonical_JJ sites_NNS and_CC examined_VBD the_DT sequence_NN preferences_NNS of_IN M.HaeIII_NP for_IN non-canonical_JJ sites_NNS ._SENT We_PP observe_VBP that_IN M.HaeIII_NP can_MD methylate_VB cytosines_NNS in_IN a_DT variety_NN of_IN sequence_NN contexts_NNS both_CC in_IN vitro_NN and_CC in_IN vivo_RB ._SENT Oligonucleotides_NN |_SYM Haesubplus_NP :_: 5'-TTCGAGAAGCTGAGGCCGGCGTACC_NP TGGAG-3_NP '_POS Haesubminus_NP :_: 5'-CTCCAGGTACGCCGGCCTCAGCTTC_NP TCGAA-3_NP '_POS Starsubplus_NP :_: 5'-TTCGAGAAGCTGAAGCCGGCGTACC_NP TGGAG-3_NP '_POS Starsubminus_NP :_: 5'-CTCCAGGTACGCCGGCTTCAGCTTC_NP TCGAA-3_NP '_POS GST1Fo_NP :_: 5'-GAAATAGTTATGATTATGATTATGT_NP TAAGT-3_NP '_POS GST1Ba_NP :_: 5'-TCTTTCTTATTATTCCACAACACCA_NP TATAC-3_NP '_POS GST2Fo_NP :_: 5'-TAATTACCCTAAATTATTAAAACAT_NP CCACA-3_NP '_POS GST2Ba_NP :_: 5'-GTTGTTTTGTTGTTTGGGGTAGTTG_NP GGGAT-3_NP '_POS Pet1Fo_NP :_: 5'-GGGAGACCATGGTTTTGATTTTTTA_NP TGTTGGATGTATTG-3_NP '_POS Pet1Ba_NP :_: 5'-CACAACGAGCTCAATAATCAACCCA_NP CTAACACATTACAC-3_NP '_POS Pet2Fo_NP :_: 5'-GGGAGACCATGGTCTCAATCCTCTA_NP CACCAAACACATC-3_NP '_POS Pet2Ba_NP :_: 5'-CACAACGAGCTCGATGTGTTGTGTG_NP AGAAGATTGTGTATTGTTG-3_NP '_POS cM1-Clon-F_NN :_: 5'-ATCGATCGGTACCTTATTACTCTTT_NP CTTGTTGTTCCACAGCGC-3_NP '_POS cM1-Clon-B_NN :_: 5'-TATCCTGAGCCATGGTGGTTACCCT_NP GGGTTATTG-3_NP '_POS Re-N-Flag-Bc_NP :_: 5'-GCTGACAAGCTTAATAATTTTGTTT_NP AACTTTAAGAAGGAGATATAGCCATG_NP GACCTACAAGATGACGATGATAAAA_NP ATTTAATTAGTCTTT-3_NP '_POS In_IN vitro_NN methylation_NN with_IN S-adenosyl-l-[methyl-3H]methionine_NP |_SYM Complementary_JJ oligonucleotides_NNS Haesubplus_NP and_CC Haesub_NP minus_CC were_VBD annealed_VBN by_IN heating_VBG equal_JJ amounts_NNS (_( 0.5_CD mM_NNS each_DT in_IN 10_CD mM_NP Tris_NP --_: HCl_NP ,_, pH_NN 8.5_CD )_) to_TO 90C_NN for_IN 5_CD min_NN and_CC then_RB cooling_VBG slowly_RB to_TO 20C_JJ to_TO create_VB a_DT 30_CD bp_NN template_NN for_IN methylation_NN ,_, termed_VBN Haesub_NP (_( see_VB Fig._NN A_DT )_) ,_, containing_VBG a_DT single_JJ canonical_JJ M.HaeIII_NP methylation_NN site_NN (_( GGCC_NP )_) ._SENT Similarly_RB ,_, the_DT DNA_NP oligonucleotides_NP Starsubplus_NP and_CC Starsubminus_NP were_VBD annealed_VBN to_TO create_VB a_DT second_JJ 30_CD bp_NN template_NN for_IN methylation_NN ,_, termed_VBN Starsub_NP (_( see_VB Fig._NN A_DT )_) ,_, which_WDT has_VBZ no_DT canonical_JJ HaeIII_NP sites_NNS and_CC differs_VBZ from_IN Haesub_NP by_IN only_RB a_DT single_JJ base_NN pair_NN ._SENT Incorporation_NN of_IN methyl-3H_NN into_IN the_DT two_CD DNA_NN substrates_NNS by_IN M.HaeIII_NP was_VBD assayed_VBN ._SENT Reactions_NNS contained_VBD 10_CD nM_NN M.HaeIII_NP (_( New_NP England_NP Biolabs_NP )_) ,_, 200_CD nM_NN S-adenosyl-l-[methyl-3H]methionine_NP (_( 79.8_CD Ci_NP /mmol_NN ;_: Perkin-Elmer_NP )_) and_CC 1.25_CD microM_NN double-stranded_JJ DNA_NN in_IN 30_CD microl_NN of_IN a_DT standard_JJ buffer_NN (_( 25_CD mM_NP Tris_NP --_: HCl_NP pH_NN 7.5_CD ,_, 25_CD mM_NP NaCl_NP ,_, 10_CD mM_NP dithioerythritol_NN ,_, 0.2_CD mg_NN /ml_NN BSA_NP )_) ._SENT In_IN parallel_JJ reactions_NNS the_DT concentration_NN of_IN NaCl_NP was_VBD varied_VBN in_IN the_DT range_NN 0_CD --_: 100_CD mM_NN ,_, Tris_NP --_: HCl_NP in_IN the_DT range_NN 5_CD --_: 100_CD mM_NN and_CC glycerol_NN in_IN the_DT range_NN 0_CD --_: 50_CD %_NN ,_, keeping_VBG the_DT other_JJ two_CD variables_NNS constant_JJ (_( see_VB Fig._NN )_) ._SENT Reactions_NNS were_VBD performed_VBN in_IN triplicate_NN ,_, incubated_VBN at_IN 37C_JJ and_CC stopped_VBN by_IN the_DT addition_NN of_IN 10_CD microl_NN of_IN 0.3_CD M_NP sodium_NN acetate_NN and_CC 320_CD microM_NN unlabelled_JJ S-adenosyl-l-methionine_NP ._SENT The_DT rate_NN of_IN incorporation_NN of_IN methyl-3H_NN into_IN Haesub_NP was_VBD linear_JJ for_IN at_IN least_JJS 20_CD min_NN and_CC the_DT rate_NN of_IN incorporation_NN into_IN Starsub_NP was_VBD linear_JJ for_IN 2_CD h_NN (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO measure_VB the_DT initial_JJ rate_NN ,_, reactions_NNS were_VBD quenched_VBN after_IN 10_CD min_NN (_( Haesub_NP )_) or_CC after_IN 40_CD min_NN (_( Starsub_NP )_) ._SENT Thirty-five_JJ microlitres_NNS of_IN the_DT quenched_VBN reaction_NN was_VBD spotted_VBN onto_IN a_DT Whatman_NP DE81_NP filter_NN ._SENT Filters_NNS were_VBD washed_VBN four_CD times_NNS with_IN 2_CD ml_NN of_IN 0.2_CD M_NP ammonium_NN hydrogen_NN carbonate_NN ,_, twice_RB with_IN 1_CD ml_NN of_IN ethanol_NN ,_, air_NN dried_VBD and_CC counted_VBD using_VBG a_DT Beckmann_NP LS6000SC_NP scintillation_NN counter_NN in_IN 3_CD ml_NN of_IN scintillant_NN (_( National_NP Diagnostics_NP )_) ._SENT The_DT concentration_NN of_IN S-adenosylmethionine_NP in_IN the_DT assays_NNS (_( 200_CD nM_NN )_) was_VBD lower_JJR than_IN the_DT Km_NP of_IN M.HaeIII_NP for_IN S-adenosylmethionine_NP (_( 336_CD nM_NN ;_: H.M.Cohen_NP ,_, unpublished_JJ results_NNS )_) ;_: however_RB ,_, the_DT use_NN of_IN low_JJ concentrations_NNS of_IN cofactor_NN with_IN high_JJ specific_JJ radioactivity_NN was_VBD necessary_JJ to_TO allow_VB sensitive_JJ detection_NN of_IN methyl_NN group_NN incorporation_NN ._SENT Determining_VBG the_DT methylation_NN pattern_NN of_IN DNA_NP in_IN vitro_NP |_SYM The_DT chicken_NN glutathione-S-transferase_NN M1-1_JJ gene_NN was_VBD amplified_VBN from_IN chicken_NN liver_NN cDNA_NN (_( Clontech_NP )_) using_VBG primers_NNS cM1-Clon-F_NN and_CC cM1-Clon-B_NN ,_, digested_VBN with_IN NcoI_NP and_CC KpnI_NP and_CC ligated_VBN into_IN pGEM4z_NP (_( Promega_NP )_) ._SENT PCR_NP amplification_NN of_IN this_DT plasmid_NN ,_, using_VBG the_DT standard_NN --_: 21M13_JJ forward_JJ and_CC M13_JJ reverse_NN sequencing_VBG primers_NNS ,_, yielded_VBD an_DT 832_CD bp_NN template_NN for_IN methylation_NN ._SENT The_DT methylation_NN reaction_NN contained_VBD 100_CD nM_NN M.HaeIII_NP (_( New_NP England_NP Biolabs_NP )_) ,_, 73_CD nM_NN PCR_NP fragment_NN (_( purified_VBD using_VBG the_DT Wizard_NP PCR_NP purification_NN kit_NN ;_: Promega_NP )_) ,_, and_CC 80_CD microM_NN S-adenosyl_NN methionine_NN in_IN 50_CD microl_NN of_IN buffer_NN (_( 25_CD mM_NP NaCl_NP ,_, 25_CD mM_NP Tris_NP --_: HCl_NP pH_NN 8.5_CD ,_, 5_CD mM_NP DTT_NP ,_, 40_CD %_NN glycerol_NN )_) ._SENT The_DT reaction_NN was_VBD incubated_VBN for_IN 8_CD h_NN at_IN 37C_JJ ,_, with_IN an_DT additional_JJ 80_CD microM_NP S-adenosyl_NP methionine_NN added_VBD after_IN 4_CD h._NNS The_DT DNA_NN was_VBD purified_VBN (_( Wizard_NP PCR_NP purification_NN kit_NN )_) ,_, treated_VBN with_IN bisulphite_NN and_CC sequenced_JJ as_RB described_VBN below_RB ._SENT An_DT unmethylated_JJ sample_NN of_IN the_DT PCR_NP fragment_NN was_VBD treated_VBN with_IN bisulphite_NN in_IN a_DT parallel_JJ reaction_NN ._SENT Determination_NN of_IN the_DT methylation_NN pattern_NN of_IN DNA_NN in_IN vivo_RB |_SYM The_DT M.HaeIII_NP gene_NN was_VBD amplified_VBN by_IN PCR_NP from_IN H.influenzae_NP (_( biogroup_NP aegyptius_NP )_) (_( ATCC_NP 11116_CD )_) using_VBG oligonucleotides_NNS HaeIII-FoNC_NP and_CC HaeIII-Bc_NP ,_, digested_VBN with_IN KpnI_NP and_CC HindIII_NP and_CC ligated_VBN into_IN pGEM4Z_NP (_( Promega_NP )_) ._SENT The_DT gene_NN was_VBD amplified_VBN from_IN this_DT plasmid_NN by_IN PCR_NP using_VBG oligonucleotides_NNS Re-N-Flag-Bc_NP and_CC LMB2-Nest_NP ,_, digested_VBN with_IN NcoI_NP and_CC SacI_NP ,_, ligated_VBN into_IN pET30a_NP (_( Invitrogen_NP )_) creating_VBG pET-MHaeIII_NNS ,_, and_CC transformed_VBN into_IN Escherichia_NP coli_NNS C41(DE3)_NP ._SENT The_DT expressed_VBN protein_NN has_VBZ N-terminal_JJ His6_NN ,_, S_NP and_CC Flag_NP tags_NNS ._SENT Cells_NNS were_VBD grown_VBN in_IN 2x_NP YT_NP at_IN 37C_NP to_TO OD_NP 0.6_CD ,_, induced_VBN by_IN the_DT addition_NN of_IN 0.3_CD mM_NP isopropyl-beta-d-thiogalactoside_NN and_CC transferred_VBN to_TO 30C_JJ for_IN 4_CD h._NP M.HaeIII_NP was_VBD purified_VBN from_IN the_DT cells_NNS using_VBG NiNTA_NP agarose_NP (_( Qiagen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT pET-MHaeIII_NP plasmid_NP was_VBD also_RB prepared_VBN from_IN the_DT induced_VBN cells_NNS using_VBG the_DT Qiagen_NP Plasmid_NP Midi-prep_NP kit_NN ._SENT Fifty-six_NP nanograms_NNS of_IN plasmid_NP was_VBD linearised_VBN by_IN digestion_NN with_IN SacI_NP ,_, purified_VBN (_( Qiaquick_NP PCR_NP purification_NN kit_NN ;_: Qiagen_NP )_) ,_, treated_VBN with_IN bisulphite_NN and_CC sequenced_JJ as_RB described_VBN below_RB ._SENT pET30a_NP (_( containing_VBG no_DT methyltransferase_NN gene_NN )_) was_VBD prepared_VBN from_IN E.coli_NP C41(DE3)_NP after_IN induction_NN ,_, as_RB above_RB ,_, for_IN use_NN in_IN a_DT parallel_JJ bisulphite_NN reaction_NN ._SENT Bisulphite_NN sequencing_NP |_SYM Purified_JJ methylated_VBN DNA_NN was_VBD treated_VBN with_IN bisulphite_NN as_IN described_VBN ._SENT Strand_NP 1_CD of_IN the_DT bisulphite-converted_JJ GST_JJ gene_NN was_VBD amplified_VBN using_VBG primers_NNS GST1Fo_NP and_CC GST1Rev_NP ,_, strand_NN 2_CD was_VBD amplified_VBN with_IN GST2Fo_NP and_CC GST2Rev_NP ._SENT PCR_NP products_NNS were_VBD cloned_VBN using_VBG the_DT TOPO_NP TA_NP Cloning_NP kit_NN (_( Invitrogen_NP )_) and_CC sequenced_JJ ._SENT Strand_NP 1_CD of_IN the_DT bisulphite-converted_JJ pET_NN plasmid_NN was_VBD amplified_VBN using_VBG Pet1Fo_NP and_CC Pet1Rev_NP and_CC strand_VB 2_CD was_VBD amplified_VBN using_VBG Pet2Fo_NP and_CC Pet2Rev_NP ._SENT PCR_NP products_NNS were_VBD digested_VBN with_IN NcoI_NP and_CC SacI_NP ,_, cloned_VBN in_IN pIVEX2.2_NN (_( Roche_NP )_) and_CC sequenced_JJ ._SENT Figure_NP 1_CD |_SYM In_IN vitro_NN methylation_NN rates_NNS of_IN substrate_NN DNA_NN containing_VBG canonical_JJ and_CC non-canonical_JJ sites_NNS by_IN M.HaeIII_NP ._SENT In_IN vitro_NN methylation_NN rates_NNS of_IN substrate_NN DNA_NN containing_VBG canonical_JJ and_CC non-canonical_JJ sites_NNS by_IN M.HaeIII_NP ._SENT Two_CD 30_CD bp_NN substrates_NNS were_VBD used_VBN (_( A_NP )_) ,_, differing_VBG by_IN only_RB a_DT single_JJ base_NN pair_NN :_: Haesub_NP contained_VBD a_DT single_JJ canonical_JJ site_NN (_( GGCC_NP )_) ,_, shown_VBN in_IN bold_JJ ;_: and_CC Starsub_NP differed_VBD at_IN one_CD base_NN pair_NN ,_, shown_VBN in_IN bold_JJ ,_, and_CC lacked_VBD canonical_JJ sites_NNS ._SENT Initial_JJ rates_NNS of_IN incorporation_NN of_IN methyl-3H_NN into_IN Haesub_NP (_( continuous_JJ line_NN ,_, squares_NNS )_) and_CC Starsub_NP (_( dashed_VBN line_NN ,_, triangles_NNS )_) at_IN various_JJ concentrations_NNS of_IN glycerol_NN (_( B_NP )_) ,_, NaCl_NP (_( C_NP )_) and_CC Tris_NP --_: HCl_NP (_( D_NP )_) ._SENT Measurements_NNS were_VBD taken_VBN in_IN triplicate_NN and_CC error_NN bars_NNS represent_VBP one_CD standard_JJ error_NN of_IN the_DT mean_NN ._SENT The_DT relative_JJ rates_NNS of_IN methylation_NN of_IN two_CD substrates_NNS ,_, Haesub_NP ,_, which_WDT contains_VBZ a_DT single_JJ canonical_JJ M.HaeIII_NP methylation_NN site_NN (_( GGCC_NP )_) ,_, and_CC Starsub_NP ,_, which_WDT has_VBZ no_DT canonical_JJ HaeIII_NP sites_NNS and_CC differs_VBZ from_IN Haesub_NP by_IN only_RB a_DT single_JJ base_NN pair_NN (_( Fig._NN A_NP )_) ,_, were_VBD determined_VBN under_IN a_DT variety_NN of_IN different_JJ conditions_NNS in_IN vitro_NN ._SENT It_PP is_VBZ well_RB known_VBN that_IN the_DT star_JJ activity_NN of_IN restriction_NN enzymes_NNS is_VBZ greatly_RB enhanced_VBN under_IN conditions_NNS of_IN low_JJ ionic_JJ strength_NN or_CC high_JJ glycerol_NN concentrations_NNS ;_: therefore_RB ,_, we_PP investigated_VBD whether_IN the_DT star_JJ activity_NN of_IN M.HaeIII_NP could_MD be_VB enhanced_VBN under_IN similar_JJ conditions_NNS ._SENT Under_IN all_DT conditions_NNS tested_VBD ,_, the_DT rate_NN of_IN methylation_NN of_IN the_DT non-canonical_JJ substrate_NN ,_, Starsub_NP ,_, was_VBD significant_JJ ,_, ranging_VBG between_IN 2.8_CD and_CC 50.8_CD %_NN of_IN the_DT rate_NN with_IN the_DT canonical_JJ substrate_NN ,_, Haesub_NP ,_, under_IN the_DT same_JJ conditions_NNS ._SENT Both_CC the_DT absolute_JJ rates_NNS and_CC relative_JJ rates_NNS of_IN methylation_NN of_IN the_DT two_CD substrates_NNS were_VBD dependent_JJ on_IN the_DT reaction_NN conditions_NNS ._SENT The_DT fastest_JJS rate_NN of_IN methylation_NN of_IN Haesub_NP is_VBZ achieved_VBN in_IN 25_CD mM_NP NaCl_NP and_CC 25_CD --_: 50_CD mM_NP Tris_NP --_: HCl_NP ._SENT The_DT reaction_NN is_VBZ inhibited_VBN by_IN glycerol_NN ,_, with_IN an_DT almost_RB 4-fold_JJ reduction_NN in_IN rate_NN caused_VBN by_IN the_DT addition_NN of_IN glycerol_NN to_TO 50_CD %_NN (_( Fig._NN B_NN )_) ._SENT Unlike_IN Haesub_NP the_DT rate_NN of_IN methylation_NN of_IN Starsub_NP is_VBZ increased_VBN by_IN the_DT addition_NN of_IN glycerol_NN (_( Fig._NN B_NP )_) ,_, and_CC is_VBZ higher_JJR in_IN 100_CD mM_NP NaCl_NP than_IN at_IN lower_JJR salt_NN concentrations_NNS (_( Fig._NN C_NP )_) ._SENT The_DT dependence_NN on_IN Tris_NP --_: HCl_NP concentration_NN mirrors_VBZ that_IN of_IN HaeSub_NP (_( Fig._NN D_NP )_) and_CC the_DT optimum_JJ pH_NN for_IN methylation_NN of_IN both_DT substrates_NNS is_VBZ between_IN 7.0_CD and_CC 8.0_CD (_( data_NNS not_RB shown_VBN )_) ._SENT Under_IN the_DT optimal_JJ conditions_NNS for_IN methylation_NN of_IN Haesub_NP the_DT substrate_NN lacking_VBG a_DT canonical_JJ site_NN ,_, Starsub_NP ,_, is_VBZ methylated_VBN 35.7-fold_JJ more_RBR slowly_RB ._SENT However_RB ,_, the_DT highest_JJS rate_NN of_IN non-canonical_JJ methylation_NN occurred_VBD in_IN 25_CD mM_NP Tris_NP --_: HCl_NP ,_, 25_CD mM_NP NaCl_NP and_CC 50_CD %_NN glycerol_NN ,_, when_WRB Haesub_NP is_VBZ methylated_VBN only_JJ 1.97-fold_NN faster_RBR than_IN Starsub_NP ._SENT The_DT pattern_NN of_IN DNA_NN methylation_NN by_IN M.HaeIII_NP was_VBD determined_VBN both_CC in_IN vitro_NN and_CC in_IN vivo_RB by_IN bisulphite_NN modification_NN and_CC sequencing_VBG of_IN methylated_VBN DNA_NN ._SENT This_DT chemical_JJ treatment_NN results_NNS in_IN deamination_NN of_IN all_PDT the_DT unmethylated_JJ cytosines_NNS to_TO uracil_NN ,_, which_WDT is_VBZ copied_VBN as_IN thymine_NN in_IN the_DT subsequent_JJ PCR_NP ._SENT C5-methylated_JJ cytosines_NNS react_VBP more_RBR slowly_RB and_CC remain_VB unconverted_VBN ._SENT To_TO assay_VB methylation_NN in_IN vitro_NP ,_, an_DT 832_CD bp_NN DNA_NN fragment_NN encoding_VBG the_DT chicken_NN glutathione-S-transferase_NN M1-1_JJ gene_NN was_VBD incubated_VBN with_IN purified_VBN M.HaeIII_NP in_IN a_DT buffer_NN chosen_VBN to_TO maximise_VB the_DT rate_NN of_IN non-canonical_JJ DNA_NN methylation_NN (_( see_VB Fig._NN )_) ._SENT For_IN methylation_NN of_IN pET-MHaeIII_NNS in_IN vivo_RB ,_, the_DT rate_NN of_IN methylation_NN was_VBD also_RB enhanced_VBN by_IN overexpressing_VBG M.HaeIII_NP in_IN E.coli_NP ._SENT A_DT total_NN of_IN 3.1_CD mg_NN of_IN M.HaeIII_NP was_VBD purified_VBN from_IN 7.8_CD g_NN of_IN bacteria_NNS (_( data_NNS not_RB shown_VBN )_) which_WDT corresponds_VBZ to_TO an_DT approximate_JJ intracellular_JJ concentration_NN of_IN 9.15_CD microM_NN enzyme_NN (_( assuming_VBG a_DT density_NN of_IN 1_CD g_NN /ml_NN and_CC an_DT Mr_NN of_IN the_DT tagged_VBN protein_NN of_IN 43_CD 412_CD Da_NP )_) ._SENT After_IN methylation_NN ,_, the_DT DNA_NP fragment_NN encoding_VBG glutathione-S-transferase_NN was_VBD purified_VBN from_IN the_DT in_IN vitro_NN reactions_NNS and_CC pET-MHaeIII_NNS was_VBD purified_VBN from_IN the_DT induced_VBN E.coli_NP ._SENT This_DT DNA_NN was_VBD then_RB treated_VBN with_IN bisulphite_NN ._SENT Sequencing_VBG of_IN M.HaeIII-methylated_JJ ,_, bisulphite-treated_JJ DNA_NN before_IN cloning_VBG only_RB revealed_VBN methyl_NN cytosine_NN at_IN canonical_JJ sites_NNS (_( data_NNS not_RB shown_VBN )_) ,_, as_IN this_DT method_NN displays_VBZ an_DT average_NN of_IN all_PDT the_DT strands_NNS ._SENT Cloning_VBG the_DT bisulphite-treated_JJ DNA_NN allowed_VBD the_DT analysis_NN of_IN individual_JJ strands_NNS (_( Table_NP and_CC Fig._NN )_) ._SENT 22_CD 870_CD bases_NNS of_IN in_IN vitro-methylated_JJ DNA_NN and_CC 12_CD 730_CD bases_NNS of_IN in_IN vivo-methylated_JJ DNA_NN were_VBD sequenced_JJ ._SENT The_DT percentage_NN of_IN canonical_JJ HaeIII_NP sites_NNS methylated_VBN in_IN vitro_NN was_VBD 90.3_CD %_NN and_CC the_DT percentage_NN of_IN canonical_JJ sites_NNS in_IN pET-MHaeIII_NNS methylated_VBN in_IN vivo_RB was_VBD 100_CD %_NN ._SENT In_IN addition_NN to_TO these_DT sites_NNS ,_, a_DT further_JJR 0.9_CD %_NN of_IN all_DT other_JJ cytosines_NNS in_IN the_DT PCR_NP fragment_NN and_CC 0.6_CD %_NN in_IN pET-MHaeIII_NNS remained_VBD unconverted_JJ ._SENT More_JJR than_IN half_NN of_IN these_DT unconverted_JJ cytosines_NNS were_VBD M.HaeIII_NP star_NN sites_NNS ,_, with_IN unconverted_JJ cytosines_NNS observed_VBN at_IN seven_CD of_IN the_DT nine_CD possible_JJ star_NN sites_NNS ._SENT Additionally_RB ,_, 28_CD unconverted_JJ cytosines_NNS were_VBD observed_VBN in_IN sequence_NN contexts_NNS differing_VBG by_IN two_CD or_CC three_CD bases_NNS from_IN the_DT canonical_JJ site_NN ;_: 19_CD in_IN vitro_NN and_CC nine_CD in_IN vivo_JJ ._SENT However_RB ,_, unconverted_JJ cytosines_NNS ,_, in_IN addition_NN to_TO arising_VBG from_IN DNA_NN methylation_NN ,_, may_MD also_RB be_VB due_JJ to_TO incomplete_JJ chemical_NN reaction_NN of_IN the_DT DNA_NN with_IN bisulphite_NN or_CC mutagenesis_NN in_IN the_DT subsequent_JJ PCR_NP causing_VBG a_DT T_NN to_TO C_NP transition_NN ._SENT To_TO test_VB the_DT background_NN level_NN of_IN unconverted_JJ cytosines_NNS ,_, the_DT unmethylated_JJ PCR_NP fragment_NN and_CC unmethylated_JJ pET30a_NN were_VBD subjected_VBN to_TO bisulphite_NN sequencing_NP ._SENT A_DT total_NN of_IN 7640_CD bases_NNS of_IN the_DT bisulphite-treated_NN ,_, cloned_VBN glutathione-S-transferase_NN gene_NN and_CC 3350_CD bases_NNS of_IN the_DT bisulphite-treated_NN ,_, cloned_VBN ,_, pET30a_NN were_VBD sequenced_JJ ._SENT The_DT percentage_NN of_IN cytosines_NNS remaining_VBG unconverted_JJ in_IN these_DT samples_NNS was_VBD 0.7_CD and_CC 0.1_CD %_NN ,_, respectively_RB ._SENT No_DT bias_NN in_IN the_DT sequence_NN context_NN of_IN unconverted_JJ cytosines_NNS was_VBD observed_VBN :_: of_IN the_DT 64_CD permutations_NNS of_IN NNCN_NP ,_, 51_CD were_VBD never_RB observed_VBN unconverted_JJ ,_, 12_CD were_VBD observed_VBN unconverted_VBN only_RB once_RB ,_, and_CC only_RB one_CD site_NN (_( CGCC_NP )_) was_VBD observed_VBN unconverted_VBN twice_RB ._SENT Methylated_VBN DNA_NN ,_, in_IN contrast_NN ,_, has_VBZ a_DT strongly_RB biased_VBN pattern_NN of_IN non-canonical_JJ unconverted_JJ cytosines_NNS that_WDT cannot_MD be_VB explained_VBN simply_RB by_IN incomplete_JJ reaction_NN with_IN bisulphite_NN ._SENT Figure_NP 2_CD |_SYM Typical_JJ sequences_NNS of_IN the_DT methylation_NN template_NN before_IN bisulphite_NN treatment_NN (_( A_NP )_) ,_, after_IN bisulphite_NN conversion_NN and_CC cloning_VBG (_( B_NP )_) and_CC after_IN in_IN vitro_NN methylation_NN by_IN M.HaeIII_NP ,_, bisulphite_NN treatment_NN and_CC cloning_VBG (_( C_NP )_) ._SENT Typical_JJ sequences_NNS of_IN the_DT methylation_NN template_NN before_IN bisulphite_NN treatment_NN (_( A_NP )_) ,_, after_IN bisulphite_NN conversion_NN and_CC cloning_VBG (_( B_NP )_) and_CC after_IN in_IN vitro_NN methylation_NN by_IN M.HaeIII_NP ,_, bisulphite_NN treatment_NN and_CC cloning_VBG (_( C_NP )_) ._SENT Figure_NP 3_CD |_SYM Frequency_NN of_IN occurrence_NN of_IN C5_NP methyl-cytosine_NN groups_NNS in_IN a_DT glutathione-S-transferase_NN gene_NN methylated_VBN in_IN vitro_NN by_IN M.HaeIII_NP determined_VBN by_IN bisulphite_NN treatment_NN and_CC sequencing_VBG of_IN individual_JJ clones_NNS ._SENT Frequency_NN of_IN occurrence_NN of_IN C5_NP methyl-cytosine_NN groups_NNS in_IN a_DT glutathione-S-transferase_NN gene_NN methylated_VBN in_IN vitro_NN by_IN M.HaeIII_NP determined_VBN by_IN bisulphite_NN treatment_NN and_CC sequencing_VBG of_IN individual_JJ clones_NNS ._SENT The_DT sequences_NNS of_IN both_DT strands_NNS of_IN the_DT gene_NN are_VBP shown_VBN ,_, with_IN canonical_JJ HaeIII_NP sites_NNS shown_VBN in_IN red_NN ._SENT Bars_NNS above_IN the_DT sequence_NN indicate_VBP unconverted_JJ cytosines_NNS in_IN the_DT top_JJ strand_NN and_CC bars_NNS below_IN the_DT unconverted_JJ cytosines_NNS in_IN the_DT bottom_JJ strand_NN ._SENT The_DT height_NN of_IN the_DT bars_NNS represent_VBP the_DT percentage_NN of_IN unconverted_JJ cytosines_NNS at_IN each_DT position_NN with_IN a_DT scale_NN of_IN 0_CD --_: 50_CD %_NN ._SENT All_DT canonical_JJ HaeIII_NP sites_NNS were_VBD unconverted_VBN in_IN >50_JJ %_NN of_IN the_DT clones_NNS analysed_VBD ._SENT PCR_NP amplification_NN of_IN the_DT top_JJ strand_NN yields_VBZ a_DT 583_CD bp_NN product_NN and_CC the_DT bottom_JJ strand_NN gives_VBZ a_DT 480_CD bp_NN product_NN ._SENT Table_NP 1_CD |_SYM The_DT sequence_NN context_NN of_IN C5_NP methyl_NN cytosines_NNS detected_VBN in_IN DNA_NN methylated_VBN by_IN M.HaeIII_NP in_IN vitro_NP and_CC in_IN vivo_RB Traditionally_RB ,_, DNA_NP methyltransferases_NNS are_VBP viewed_VBN as_IN highly_RB sequence_NN specific_NN ._SENT However_RB ,_, recent_JJ observations_NNS ,_, including_VBG this_DT study_NN ,_, suggest_VBP that_DT methylation_NN of_IN non-canonical_JJ sites_NNS may_MD be_VB a_DT common_JJ feature_NN of_IN DNA_NN methyltransferases_NNS ._SENT Non-canonical_JJ methylation_NN was_VBD first_RB reported_VBN for_IN the_DT adenine_NN N6_NP methyltransferase_NP M.EcoRI_NP and_CC has_VBZ since_RB been_VBN reported_VBN for_IN two_CD other_JJ adenine_NN N6_NN methyltransferases_NNS ,_, M.FokI_NP and_CC M.EcoRV_NP ._SENT Twenty-seven_JJ oligonucleotides_NNS were_VBD tested_VBN as_IN substrates_NNS for_IN methylation_NN by_IN the_DT M.FokI_NP DNA_NP methyltransferase_NN ._SENT The_DT enzyme_NN has_VBZ two_CD domains_NNS ,_, each_DT methylating_VBG one_CD strand_NN of_IN its_PP$ asymmetric_JJ recognition_NN site_NN ,_, GGATG_NP ._SENT Whilst_IN the_DT N-terminal_JJ domain_NN only_RB methylated_VBD one_CD star_NN site_NN ,_, the_DT C-terminal_NP domain_NN methylated_VBD most_JJS of_IN the_DT star_NN sites_NNS tested_VBN and_CC two_CD sites_NNS differing_VBG by_IN two_CD base_NN pairs_NNS from_IN the_DT canonical_JJ site_NN ._SENT M.EcoRV_NP (_( canonical_JJ site_NN GATATC_NP )_) is_VBZ also_RB capable_JJ of_IN methylating_VBG five_CD different_JJ degenerate_JJ EcoRV_NP recognition_NN sites_NNS ,_, including_VBG one_CD site_NN with_IN three_CD altered_JJ bases_NNS (_( GATC_NP )_) (_( ,_, )_) ._SENT Methylation_NN of_IN non-canonical_JJ sites_NNS has_VBZ also_RB been_VBN reported_VBN for_IN three_CD cytosine_NN C5_NN methyltransferases_NNS ._SENT Overexpression_NN of_IN M.HpaII_NP (_( canonical_JJ site_NN CCGG_NP )_) ,_, Dcm_NP and_CC EcoRII_NP (_( CCAGG_NP )_) methyltransferases_NNS in_IN E.coli_NP causes_VBZ an_DT increase_NN in_IN the_DT C_NP --_: T_NN mutation_NN rate_NN at_IN the_DT canonical_JJ sites_NNS for_IN methylation_NN ,_, but_CC also_RB at_IN some_DT non-canonical_JJ sites_NNS (_( CAGG_NP and_CC CCGGG_NP )_) ._SENT Restriction_NN digestion_NN of_IN the_DT plasmid_NN isolated_VBN from_IN E.coli_NP overexpressing_NP M.EcoRII_NP showed_VBD that_IN the_DT DNA_NN was_VBD partially_RB protected_VBN from_IN digestion_NN at_IN the_DT site_NN CCCGGG_NN ._SENT Methylation_NN of_IN this_DT star_JJ site_NN by_IN M.EcoRII_NP was_VBD confirmed_VBN using_VBG a_DT synthetic_JJ oligonucleotide_NN in_IN vitro_NN ._SENT In_IN these_DT studies_NNS ,_, methylation_NN of_IN a_DT target_NN cytosine_NN or_CC adenine_NN was_VBD examined_VBN in_IN a_DT limited_JJ number_NN of_IN sequence_NN contexts_NNS ._SENT Here_RB we_PP attempted_VBD to_TO explore_VB the_DT full_JJ range_NN of_IN sequence_NN contexts_NNS for_IN methylation_NN of_IN cytosine_NN residues_NNS by_IN M.HaeIII_NP ._SENT The_DT pattern_NN of_IN methylation_NN was_VBD investigated_VBN both_CC in_IN vitro_NN ,_, using_VBG purified_VBN enzyme_NN ,_, and_CC in_IN vivo_JJ in_IN E.coli_NP overexpressing_NN methyltransferase_NN ._SENT The_DT pattern_NN of_IN non-canonical_JJ DNA_NP methylation_NN was_VBD similar_JJ in_IN vitro_NN and_CC in_IN vivo_RB ._SENT Of_IN the_DT 63_CD permutations_NNS of_IN NNCN_NP (_( excepting_VBG GGCC_NP )_) ,_, 25_CD were_VBD unconverted_VBN by_IN bisulphite_NN modification_NN at_IN least_JJS once_RB in_IN the_DT clones_NNS analysed_VBD ._SENT Methylation_NN of_IN non-canonical_JJ sites_NNS was_VBD not_RB uniform_JJ ,_, either_CC in_IN vitro_NN or_CC in_IN vivo_RB ,_, M.HaeIII_NP methylates_VBZ star_NN sites_NNS more_RBR frequently_RB than_IN other_JJ sites_NNS ._SENT Only_RB at_IN two_CD of_IN the_DT nine_CD star_NN sites_NNS was_VBD methylation_NN not_RB detected_VBD either_RB in_IN vitro_NN or_CC in_IN vivo_RB ._SENT The_DT enzyme_NN shows_VBZ less_JJR discrimination_NN at_IN the_DT first_JJ and_CC fourth_JJ base_NN of_IN its_PP$ recognition_NN sequence_NN ,_, with_IN the_DT central_JJ cytosine_NN of_IN AGCC_NP being_VBG methylated_VBN more_RBR frequently_RB than_IN all_DT other_JJ non-canonical_JJ cytosines_NNS ,_, in_IN vitro_NN and_CC in_IN vivo_RB ._SENT The_DT star_NN sites_NNS GTCC_NP and_CC GCCC_NP were_VBD never_RB observed_VBN unconverted_JJ ,_, and_CC in_IN only_RB one_CD case_NN was_VBD the_DT third_JJ base_NN of_IN GACC_NP unconverted_VBN ,_, indicating_VBG a_DT greater_JJR stringency_NN for_IN recognition_NN of_IN the_DT second_JJ base_NN of_IN the_DT sequence_NN ._SENT In_IN addition_NN to_TO star_VB site_NN methylation_NN ,_, DNA_NP methylated_VBD in_IN vitro_NN and_CC in_IN vivo_RB contained_VBN unconverted_JJ cytosines_NNS at_IN sites_NNS differing_VBG from_IN the_DT canonical_JJ site_NN by_IN two_CD or_CC three_CD base_NN pairs_NNS ._SENT However_RB ,_, it_PP is_VBZ difficult_JJ to_TO be_VB sure_JJ whether_IN cytosines_NNS observed_VBD unconverted_VBN only_RB once_RB are_VBP due_JJ to_TO methylation_NN or_CC to_TO the_DT incomplete_JJ conversion_NN of_IN cytosines_NNS by_IN bisulphite_NN ._SENT Although_IN conversion_NN was_VBD very_RB efficient_JJ (_( over_IN 99.3_CD %_NN of_IN cytosines_NNS converted_VBD )_) ,_, some_DT of_IN the_DT cytosines_NNS observed_VBD in_IN the_DT methylated_VBN DNA_NN were_VBD almost_RB certainly_RB due_JJ to_TO incomplete_JJ conversion_NN ._SENT However_RB ,_, some_DT sites_NNS ,_, notably_RB AGCA_NP ,_, were_VBD observed_VBN multiple_JJ times_NNS in_IN methylated_VBN DNA_NN but_CC never_RB in_IN unmethylated_JJ DNA_NN ,_, and_CC are_VBP likely_JJ to_TO be_VB the_DT result_NN of_IN methylation_NN by_IN M.HaeIII_NP ._SENT This_DT site_NN combines_VBZ the_DT base_NN alterations_NNS of_IN two_CD star_NN sites_NNS that_WDT are_VBP methylated_VBN at_IN an_DT appreciable_JJ level_NN by_IN M.HaeIII_NP in_IN vitro_NP (_( AGCC_NP and_CC GGCA_NP )_) ._SENT In_IN E.coli_NP overexpressing_NP M.HaeIII_NP ,_, DNA_NP is_VBZ hypermethylated_JJ to_TO the_DT extent_NN that_IN the_DT central_JJ cytosine_NN of_IN the_DT sequence_NN AGCC_NN is_VBZ methylated_VBN in_IN 11.9_CD %_NN of_IN cases_NNS and_CC methylation_NN is_VBZ also_RB seen_VBN at_IN other_JJ star_NN sites_NNS ._SENT These_DT high_JJ levels_NNS of_IN methylation_NN suggests_VBZ that_IN there_EX might_MD still_RB be_VB significant_JJ levels_NNS of_IN non-canonical_JJ DNA_NN methylation_NN in_IN Haemophilus_NP aegyptius_NP ,_, despite_IN the_DT lower_JJR concentration_NN of_IN M.HaeIII_NP ._SENT The_DT in_IN vitro_NN methylation_NN rates_NNS provide_VBP further_JJR support_NN for_IN this_DT suggestion_NN as_IN the_DT enzyme_NN concentration_NN (_( 10_CD nM_NN )_) and_CC DNA_NP concentration_NN (_( 1.25_CD microM_NP sites_NNS )_) were_VBD very_RB close_JJ to_TO those_DT predicted_VBN in_IN bacteria_NNS (_( 50_CD --_: 500_CD nM_NN methylase_NN and_CC similar1_JJ --_: 10_CD microM_NN sites_NNS )_) ._SENT Even_RB under_IN the_DT conditions_NNS where_WRB the_DT enzyme_NN showed_VBD highest_JJS specificity_NN for_IN its_PP$ canonical_JJ site_NN ,_, the_DT rate_NN of_IN methylation_NN of_IN non-canonical_JJ substrate_NN was_VBD still_RB only_RB 36.7-fold_JJ lower_JJR than_IN the_DT rate_NN with_IN the_DT canonical_JJ substrate_NN ._SENT This_DT corresponds_VBZ to_TO a_DT 303-fold_JJ lower_JJR rate_NN of_IN methylation_NN per_IN cytosine_NN ,_, based_VBN on_IN two_CD canonical_JJ target_NN cytosines_NNS in_IN Haesub_NP and_CC 17_CD non-canonical_JJ cytosines_NNS in_IN Starsub_NP ._SENT The_DT existence_NN of_IN a_DT large_JJ number_NN of_IN R_NP /M_NN systems_NNS with_IN a_DT wide_JJ range_NN of_IN sequence_NN specificities_NNS raises_VBZ the_DT question_NN of_IN how_WRB methylases_NNS and_CC restriction_NN enzymes_NNS were_VBD able_JJ to_TO co-evolve_VB to_TO recognise_VB new_JJ target_NN sites_NNS ._SENT It_PP has_VBZ been_VBN proposed_VBN that_IN many_JJ enzymes_NNS can_MD catalyse_VB the_DT conversion_NN of_IN molecules_NNS which_WDT are_VBP not_RB their_PP$ principle_NN substrate_NN with_IN low_JJ efficiency_NN ,_, and_CC that_IN new_JJ enzymes_NNS may_MD evolve_VB by_IN improvements_NNS in_IN the_DT enzyme_NN 's_POS ability_NN to_TO catalyse_VB the_DT conversion_NN of_IN one_CD of_IN these_DT poor_JJ substrates_NNS (_( ,_, ,_, )_) ._SENT Promiscuous_JJ activities_NNS as_IN low_JJ as_RB described_VBN above_IN (_( and_CC indeed_RB lower_JJR )_) can_MD provide_VB a_DT selective_JJ advantage_NN and_CC thereby_RB a_DT starting_VBG point_NN for_IN the_DT evolution_NN of_IN a_DT new_JJ activity_NN ._SENT In_IN particular_JJ ,_, it_PP has_VBZ been_VBN proposed_VBN that_WDT protein_NN --_: DNA_NP interactions_NNS evolve_VBP by_IN relaxing_VBG an_DT existing_JJ specificity_NN (_( namely_RB ,_, increasing_VBG promiscuity_NN )_) and_CC then_RB restricting_VBG it_PP to_TO the_DT new_JJ target_NN ;_: this_DT principle_NN has_VBZ recently_RB been_VBN used_VBN to_TO alter_VB the_DT site_NN specificity_NN of_IN Cre_NP recombinase_NN ._SENT High_JJ levels_NNS of_IN star_JJ activity_NN by_IN restriction_NN endonucleases_NNS would_MD be_VB lethal_JJ unless_IN the_DT cognate_JJ methylase_NN also_RB had_VBD the_DT ability_NN to_TO methylate_VB and_CC protect_VB these_DT star_NN sites_NNS ._SENT The_DT problems_NNS associated_VBN with_IN non-canonical_JJ methylation_NN are_VBP probably_RB less_RBR severe_JJ ._SENT These_DT include_VBP the_DT energetic_JJ cost_NN and_CC the_DT 10-fold_NN higher_JJR mutation_NN rate_NN of_IN C5-methylated_JJ cytosines_NNS compared_VBN with_IN unmethylated_JJ cytosines_NNS (_( ,_, )_) ,_, and_CC the_DT different_JJ response_NN of_IN prokaryotic_JJ DNA-interacting_NP proteins_NNS ,_, for_IN example_NN ,_, methyl-directed_JJ restriction_NN enzymes_NNS ,_, to_TO methylated_VBN and_CC unmethylated_JJ DNA_NN ._SENT In_IN fact_NN the_DT selective_JJ disadvantage_NN attributed_VBD to_TO a_DT methyltransferase_NN with_IN two_CD distinct_JJ recognition_NN sites_NNS (_( the_DT canonical_JJ site_NN and_CC a_DT newly_RB arisen_VBN specificity_NN )_) is_VBZ comparable_JJ to_TO that_DT caused_VBN by_IN expressing_VBG two_CD different_JJ methyltransferases_NNS ,_, whereas_IN natural_JJ populations_NNS of_IN bacteria_NNS may_MD contain_VB in_IN excess_NN of_IN 10_CD different_JJ R_NN /M_NN systems_NNS ._SENT Hence_RB ,_, it_PP is_VBZ likely_JJ that_IN a_DT DNA_NN methyltransferase_NN with_IN a_DT new_JJ specificity_NN arises_VBZ before_IN the_DT cognate_JJ restriction_NN endonuclease_NN ._SENT If_IN DNA_NN methylases_NNS possess_VBP a_DT significant_JJ level_NN of_IN activity_NN at_IN non-canonical_JJ sites_NNS then_RB this_DT could_MD have_VB served_VBN as_IN a_DT starting_VBG point_NN for_IN evolutionary_JJ divergence_NN towards_IN a_DT new_JJ R_NN /M_NN site_NN (_( ,_, )_) ._SENT Type_NN II_NP R_NP /M_NN systems_NNS recognise_VBP symmetrical_JJ DNA_NN targets_VBZ 2_CD --_: 8_CD bp_NN in_IN length_NN so_IN the_DT evolution_NN of_IN a_DT new_JJ specificity_NN would_MD usually_RB involve_VB a_DT change_NN of_IN at_IN least_JJS two_CD base_JJ pairs_NNS in_IN the_DT target_NN site_NN ._SENT The_DT ability_NN of_IN M.HaeIII_NP to_TO methylate_VB cytosines_NNS in_IN a_DT variety_NN of_IN non-canonical_JJ sequence_NN contexts_NNS indicates_VBZ that_IN such_JJ changes_NNS in_IN specificity_NN may_MD not_RB represent_VB a_DT large_JJ evolutionary_JJ barrier_NN ._SENT 